Envestnet Asset Management Inc. Has $8.45 Million Position in DaVita Inc. (NYSE:DVA)

Envestnet Asset Management Inc. increased its position in shares of DaVita Inc. (NYSE:DVA) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,255 shares of the company’s stock after buying an additional 4,048 shares during the quarter. Envestnet Asset Management Inc. owned 0.07% of DaVita worth $8,452,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Epoch Investment Partners Inc. acquired a new position in shares of DaVita in the 4th quarter valued at $55,100,000. Invesco Ltd. grew its holdings in shares of DaVita by 20.9% in the 4th quarter. Invesco Ltd. now owns 1,589,545 shares of the company’s stock valued at $237,716,000 after buying an additional 275,284 shares during the period. Iron Triangle Partners LP acquired a new position in shares of DaVita in the 4th quarter valued at $38,946,000. GAMMA Investing LLC boosted its stake in DaVita by 14,695.8% in the 1st quarter. GAMMA Investing LLC now owns 234,809 shares of the company’s stock worth $35,919,000 after purchasing an additional 233,222 shares during the period. Finally, Bridgewater Associates LP boosted its stake in DaVita by 298.4% in the 4th quarter. Bridgewater Associates LP now owns 239,970 shares of the company’s stock worth $35,888,000 after purchasing an additional 179,744 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of NYSE DVA opened at $139.45 on Tuesday. DaVita Inc. has a twelve month low of $131.76 and a twelve month high of $179.60. The firm has a fifty day simple moving average of $140.11 and a 200 day simple moving average of $148.56. The company has a market capitalization of $10.53 billion, a PE ratio of 13.82, a P/E/G ratio of 0.97 and a beta of 1.11. The company has a quick ratio of 1.20, a current ratio of 1.25 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The firm had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the firm posted $2.26 earnings per share. The business’s revenue was up 5.0% compared to the same quarter last year. On average, sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Truist Financial reduced their price objective on shares of DaVita from $170.00 to $164.00 and set a “hold” rating for the company in a research note on Monday, May 19th. Wall Street Zen raised shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.